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The increasing requirements of immunosuppressed patients for blood and blood components from donors uninfected with cytomegalovirus (CMV) led us to search for a sensitive, rapid, convenient and economical test for screening blood donations for antibodies against this virus.
Initially, we used a modification of a commercial haemagglutination (HA) assay (Cetus Corporation, Berkeley, California); this entailed 10-fold dilution of the red cells provided in the kit and assessment of agglutination in a microplate inclined at 700 after centrifugation at 387g for one minute.' Although this test proved suitable for the selection of plasma with high titre anti-CMV for the manufacture of specific immunoglobulin, its sensitivity and specificity was unacceptably variable for selecting CMV free donations. This became apparent when 23% (28 of 124) donations found negative for anti-CMV by modified HA were found to be positive for CMV antibodies by radioimmunoassay. We therefore decided to use a modified latex agglutination as our routine screening test (CMV Scan, Becton and Dickinson, Baltimore, Maryland). We tested this assay in parallel with the modified HA test (MHA) using a sensitive radioimmunoassay described by Berry et al2 as a standard for comparison.
Accepted for publication 15 July 1986 Methods For the latex agglutination test 25 pl of test serum was pipetted on to black reaction cards and 15 p1 of latex coated with CMV antigen was added and mixed, according to the manufacturer's recommendations. Positive and negative control sera were also tested. The card was placed on a humidified rotator for eight minutes and then read. Samples positive for anti-CMV showed clear agglutination, whereas negative ones remained cloudy. The test was made more economical by diluting two volumes of the antigen coated latex with one volume of the titration buffer provided with the kit. Furthermore, the volumes of reagents were reduced to 15 p1 of test serum and 5 I of diluted latex. Even with these reduced volumes, the reactions could be read easily. Results Before using the modified latex test for screening donor sera, we confirmed that the reduced volume modifications, with or without dilution of the latex, provided the same end point titres as the standard method when either sera or plasma with high titre or low titre anti-CMV were assessed. When 252 donor serum samples found to give negative CMV antibody results by modified haemagglutination screen tests were rescreened under routine testing conditions by the reduced volume latex agglutination test (method A), 58 (23%) were found to be positive by the second test. These 58 samples were then retested by various methods (table 1) . A small number scored differently on this repeat testing. Table 2 gives detailed results for nine negative or "discrepant" sera at repeat testing. Furthermore, when 50 serum samples from donors found to be negative for anti-CMV by modified haemagglutination and by the two latex test modifications, were tested by monoclonal radioimmunoassay, 48 were clearly negative, and two samples showed only traces of antibody to CMV. The figure shows the No of anti-CMV negative (%) 4 (7) 5 (9) 3 (5) 5 (9) A = volumes reduced by two thirds; B = volumes reduced by two thirds and latex diluted by one third. 
